Sexual Health

More Ob/Gyns are probably discussing sex with teenage patients than pediatricians, but a new study serves as a good reminder that physicians need to initiate these conversations.

A highly specific rapid test for Chlamydia trachomatis has been developed. The best part: the new test requires a direct urine sample only (no total DNA purification needed).

Compared with hysterectomy, GNRHa is an effective treatment of uterine fibroids and has an equivalent effect on sexual function.

Research shows that vaccinating all teens-both boys and girls--results in an enormous reduction in HPV-related infections. Why aren't we doing it in the United States?

Vulvovaginal disease is common, but often difficult to diagnose. Yeast infections, vulvodynia, and contact dermatitis may be easy to identify, but chronic or overlapping conditions can be difficult to spot. Can you accurately diagnose these patients?

The increased availability of emergency contraception to women and girls irrespective of age is victory for all of us.

After treating vaginal atrophy with local estrogens, sexual satisfaction for postmenopausal women and their male partners improves, according to the results of a survey published online in the journal Menopause.

A recent discovery suggests that Trichomonas vaginalis may alter the vaginal microbiota in a manner that cultivates bacteria that is beneficial to its survival and transmissibility.

Osphena (ospemifene) has been approved by the FDA to treat dyspareunia. This is the first non-steroidal estrogen available for women with dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy (VVA) that is common during menopause.

Certain herbal and complementary medicines may be a valuable treatment option for women with postmenopausal symptoms, according to a new review outlining the advantages and limitations of the available treatments of postmenopausal symptoms.

Human papillomavirus (HPV) vaccination may be beneficial for women with HIV infection even after previous exposure to HPV, according to the findings of a new study.

A Phase II trial is underway for Tefina, a testosterone-based treatment for female sexual dysfunction.

IUDs are a safe and effective method of contraception. Why aren't we offering them to teens?

The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.

Women over the age of 25 may still need to be screened for Chlamydia trachomatis (CT) according to research released at the American Congress of Obstetricians and Gynecologists’ (ACOG) Annual Clinical Meeting.

Human papillomavirus vaccines provide still some benefit to women who have undergone treatment for HPV-related diseases, according to a new study published in the British Medical Journal.

More than one third of women in the United States will experience some form of intimate partner violence (IPV) in their lifetime. The consequences of IPV can be lifelong and include emotional trauma, long-term physical impairment, chronic health problems, and even death.

According to research published in the Annals of Family Medicine, midstream urine testing effectively detects Chlamydia trachomatis.

OBGYN.net Conference CoverageFrom the ESHRE 2001 Conference - Lausanne, Switzerland

Yeast infections are one of the most common infections occurring in women. Although they are rarely dangerous, they can be very bothersome and uncomfortable.

Genital warts, also called condylomata, is a common infection of the female reproductive tract.

With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.

Diagnosis, Transmission, and Management

One out of four Americans between 15 and 55 will catch at least one sexually transmitted infection (STI).

Anyone working with survivors of sexual assault, especially those who are college-aged or teenagers, should be aware of a new drug called Rohypnol. Rohypnol has been dubbed the "date rape drug" because of its use in sexual assaults.